Pa. provider latest to earn EMRAM Stage 7

WellSpan Surgery and Rehabilitation Hospital is the latest healthcare provider to receive the EMRAM Stage 7 award from HIMSS Analytics.

Stage 7 is the highest level of the Electronic Medical Record Adoption Model (EMRAM).

HIMSS Analytics developed the EMR Adoption Model in 2005 as a methodology for evaluating the progress and impact of EMR systems for hospitals in the HIMSS Analytics Logic.

During the third quarter of 2015, only 4.1 percent of the more than 5,400 U.S. hospitals in the HIMSS Analytics Logic received the Stage 7 Award.

“WellSpan Surgery and Rehabilitation Hospital is an exceptional facility that was built around leveraging the electronic medical record, and it is deserving of the recognition it has achieved,” said R. Hal Baker, MD, senior vice president, clinical improvement and chief information officer, WellSpan Health. “We appreciate the reviewers' particular recognition of WellSpan’s exceptional integration of biomedical devices with the electronic medical record.”

WellSpan Health is an integrated health system serving the communities of central Pennsylvania and northern Maryland. The organization is comprised of a multispecialty medical group of more than 850 physicians and advanced practice clinicians, a home care organization, six respected hospitals, more than 15,000 employees and more than 140 patient care locations.

“A couple of themes that clearly stood out during our visit to WellSpan Health included strong operational and governance support of their overall EHR efforts and a commitment to clinical leadership in their IT strategy,” said John H. Daniels, CNM, FACHE, FHIMSS, CPHIMS, global vice president, healthcare advisory services group, HIMSS Analytics. “This approach was evident in the case studies they presented that showed significant benefits realization in improved outcomes and cost savings.”

WellSpan Surgery and Rehabilitation Hospital will be recognized at the 2016 HIMSS Conference & Exhibition in Las Vegas which begins on Feb. 29.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup